Open Access

Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Topic: Chronic Heart Failure
Sponsored by AstraZeneca

Congress Session

1 more presentation in this session

Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

Speaker: Professor C. Chiang (Taipei, TW) Associate Professor J. Tan (Singapore, SG)

Thumbnail

Access the full session

Paradigm shifts in HFrEF management: SGLT2-Inhibitors

Speakers: Professor C. Chiang, Associate Professor J. Tan
Thumbnail

About the event

Image

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk